These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19766029)

  • 21. Quantitative structure activity relationship studies of diaryl furanones as selective COX-2 inhibitors.
    Shahapurkar S; Pandya T; Kawathekar N; Chaturvedi SC
    Eur J Med Chem; 2004 Apr; 39(4):383-8. PubMed ID: 15072847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and synthesis of new 1,3-benzthiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
    Zarghi A; Zebardast T; Daraie B; Hedayati M
    Bioorg Med Chem; 2009 Aug; 17(15):5369-73. PubMed ID: 19596198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of 4,5-diaryl-1H-pyrazole-3-ol derivatives as potential COX-2 inhibitors.
    Patel MV; Bell R; Majest S; Henry R; Kolasa T
    J Org Chem; 2004 Oct; 69(21):7058-65. PubMed ID: 15471453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological evaluation of new phenidone analogues as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors.
    Cusan C; Spalluto G; Prato M; Adams M; Bodensieck A; Bauer R; Tubaro A; Bernardi P; Da Ros T
    Farmaco; 2005 Jan; 60(1):7-13. PubMed ID: 15652362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substituted furans as potent lipoxygenase inhibitors: Synthesis, in vitro and molecular docking studies.
    Vinayagam J; Gajbhiye RL; Mandal L; Arumugam M; Achari A; Jaisankar P
    Bioorg Chem; 2017 Apr; 71():97-101. PubMed ID: 28143657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemical and structural diversity in cyclooxygenase protein active sites.
    Huff RG; Bayram E; Tan H; Knutson ST; Knaggs MH; Richon AB; Santago P; Fetrow JS
    Chem Biodivers; 2005 Nov; 2(11):1533-52. PubMed ID: 17191953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of ten biphenyl-neolignan derivatives and their in vitro inhibitory potency against cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4-formation.
    Schühly W; Hüfner A; Pferschy-Wenzig EM; Prettner E; Adams M; Bodensieck A; Kunert O; Oluwemimo A; Haslinger E; Bauer R
    Bioorg Med Chem; 2009 Jul; 17(13):4459-65. PubMed ID: 19481465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular biological study on enzymes involved in cyclooxygenase pathway: structure of their genes and proteins].
    Yokoyama C
    Seikagaku; 1999 Jun; 71(6):397-411. PubMed ID: 10432833
    [No Abstract]   [Full Text] [Related]  

  • 29. Exploration of binding site pattern in arachidonic acid metabolizing enzymes, Cyclooxygenases and Lipoxygenases.
    Reddy KK; Vidya Rajan VK; Gupta A; Aparoy P; Reddanna P
    BMC Res Notes; 2015 Apr; 8():152. PubMed ID: 25886468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, biological evaluation and molecular docking studies of stellatin derivatives as cyclooxygenase (COX-1, COX-2) inhibitors and anti-inflammatory agents.
    Gautam R; Jachak SM; Kumar V; Mohan CG
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1612-6. PubMed ID: 21345672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
    Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
    Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, biological evaluation, and docking studies of novel heterocyclic diaryl compounds as selective COX-2 inhibitors.
    Eren G; Unlü S; Nuñez MT; Labeaga L; Ledo F; Entrena A; Banoğlu E; Costantino G; Sahin MF
    Bioorg Med Chem; 2010 Sep; 18(17):6367-76. PubMed ID: 20692174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prostanoid synthases].
    Shimonishi M; Tanabe T
    Tanpakushitsu Kakusan Koso; 1999 Jun; 44(8 Suppl):1097-103. PubMed ID: 10396989
    [No Abstract]   [Full Text] [Related]  

  • 34. Diarylheterocycle core ring features effect in selective COX-1 inhibition.
    Perrone MG; Vitale P; Malerba P; Altomare A; Rizzi R; Lavecchia A; Di Giovanni C; Novellino E; Scilimati A
    ChemMedChem; 2012 Apr; 7(4):629-41. PubMed ID: 22278975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and biological evaluation of 6-substituted-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors.
    Praveen Rao PN; Amini M; Li H; Habeeb AG; Knaus EE
    J Med Chem; 2003 Nov; 46(23):4872-82. PubMed ID: 14584938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological manipulation of inflammation in rabbit hydronephrosis: effects of a combined cyclooxygenase/lipoxygenase inhibitor ethoxyquin, a thromboxane synthase inhibitor RS-5186 and a PAF antagonist L-659,989.
    Spaethe SM; Hsueh W; Needleman P
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1308-16. PubMed ID: 2539462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigations concerning the COX/5-LOX inhibiting and hydroxyl radical scavenging potencies of novel 4,5-diaryl isoselenazoles.
    Scholz M; Ulbrich HK; Dannhardt G
    Eur J Med Chem; 2008 Jun; 43(6):1152-9. PubMed ID: 17976864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclooxygenase-2 and 15-lipoxygenase inhibition, synthesis, anti-inflammatory activity and ulcer liability of new celecoxib analogues: Determination of region-specific pyrazole ring formation by NOESY.
    Abdelall EKA; Lamie PF; Ali WAM
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2893-2899. PubMed ID: 27158139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and SAR study of 4,5-diaryl-1H-imidazole-2(3H)-thione derivatives, as potent 15-lipoxygenase inhibitors.
    Assadieskandar A; Amini M; Salehi M; Sadeghian H; Alimardani M; Sakhteman A; Nadri H; Shafiee A
    Bioorg Med Chem; 2012 Dec; 20(24):7160-6. PubMed ID: 23117172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors.
    Gray PA; Warner TD; Vojnovic I; Del Soldato P; Parikh A; Scadding GK; Mitchell JA
    Br J Pharmacol; 2002 Dec; 137(7):1031-8. PubMed ID: 12429575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.